Nutraceuticals
Patented and preclinically supported extract that supports the function of the gastrointestinal system
(Olea europea L.)
Strengthening the integrity of the intestinal barrier
Reducing inflammation
Regulation of the intestinal immune response
Optimises the gut microbiome's composition
Beneficial actions observed in preclinical studies (7,8,9,10)
Why Oligut?
More than 40% of people worldwide suffer from chronic gastrointestinal problems (1)
Digestive diseases have a major global impact, with 7.32 billion incidents and 2.86 billion prevalent cases (2)
Gut inflammation is a major cause of many digestive disorders, as it can weaken the intestinal barrier and lead to digestive discomforts (3)
Gut inflammation may interfere with digestion and promote the development of conditions such as IBD and IBS (4)
The Gut Health Nutraceuticals Market size was estimated at 12.24 billion USD in 2024 (5)
In vivo and In vitro studies
Several pre-clinical in vivo and in vitro studies were conducted in species with high translational relevance to humans.
Reduce inflammation
Enhance the integrity of the intestinal barrier
Modulate the immune response
Improve gut microbiota
Supplementation with OLIGUT ™ in animals with LPS-induced inflammation reduced the inflammatory response by reducing IL1β levels in vivo, suggesting improved digestive and systemic well-being. (7)
Animals that were fed OLIGUT ™ showed a significant reduction in colon injury and inflammation after the administration of the inflammatory agent. (8)
OLIGUT ™ supplementation showed significantly higher plasma mannitol concentrations indicating improved nutrient absorption and reduced intestinal permeability suggesting better intestinal integrity. (7)
The bioactive olive extract rescued and even enhanced the expression of CDH1, the gene encoding the epithelial adhesion protein E-cadherin in a model of chronic inflammation, reflecting restoring of cell junctions and barrier maintenance or healing. (7)
In LPS-challenged animals, OLIGUT ™: (9)
- Helped modulate the systemic inflammatory response, preventing an overreaction of the immune system.
- Showed a protective effect against inflammation induced damage that contributed to a faster recovery of the immune system.
OLIGUT ™ treatment in vitro helped modify the intestinal microbiota composition in several ways: (10)
- By reducing the levels of pro- inflammatory or potentially pathogenic bacteria
- Increasing beneficial bacterial groups like Lactobacillus spp and Bacteroides spp
- Suggesting a selective prebiotic and antimicrobial effect
Studies results
-
Strengthens the integrity of the intestinal barrier
-
Reduces low-grade inflammation
-
Supports intestinal immune balance
-
Positively modulates the gut microbiota
-
Promotes digestive comfort and balance recovery after stress
Applications
Capsules
Gummies
Sticks
Tablets
Softgel capsules
Sources
- (1) Sperber, A.D., et al. Gastroenterology, 2021, 160(1), 99-114;
- (2) Wang, Y. et al. Gastroenterology, 2023, 165(3), 773-783;
- (3) Lechuga, S. et al. Biochim Biophys Acta Mol Cell Res, 2017, 1864(7), 1183-1194;
- (4) Pérez de Arce, E. et al. Gastroenterol Hepatol, 2022, 45(1), 66-76;
- (5) Gut Health Nutraceuticals Market by Product, Form, Distribution Channel – Global Forecast to 2030. Report no. 5910264, 2025, 360iResearch;
- (6) Patent: Quintela et al. 2019. Combination of pentacyclic triterpenes and polyphenols and derivatives thereof. (US 10,376,529 B2);
- (7) Liehr, M. et al. PLoS One, 2017, 12(3):e0174239;
- (8) INNOFENOL project;
- (9) Cangiano, L.R. et al. J Anim Sci, 2019, 97(10), 4349-4361;
- (10) BIOADA project
Tuesday, November 18, 2025
Webinar
"*" indicates required fields
Request a quote and sample
Would you like to request an estimate or samples of our products? Send us your request on this simple form and our team will get in touch with you to answer any questions you might have and to find out more about your needs.
Fields with (*) are required
"*" indicates required fields
